-
Perrigo approved for generic Prandin
DUBLIN — Perrigo Co. announced that it received final approval from the Food and Drug Administration for repaglinide tablets — a generic version of Prandin tablets — in 1-mg and 2-mg strengths. The company has started shipment of the drug. Perrigo previously launched the 0.5-mg strength in 2013.
-
Survey suggests those in search of Cupid's arrow may want to kick the smoking habit
NEW YORK — Match.com and Pfizer on Wednesday announced results from a recent survey showing that single smokers may want to consider breaking up with their cigarettes as they look for that special someone this year. Nearly 9-in-10 (89%) respondents said they prefer not to date someone who smokes, and when asked which actions were unacceptable on a first date, more said taking a smoke break (51%) than checking one’s phone (45%) or being late (40%).